clinical trial · NCT06809803
Extended-release Sodium Oxybate in Children
Narcolepsy Type 1 (NT 1)Extended-release sodium oxybateNon-extended-release oxybates
brief summary
The main objectives of this study are to determine the treatment preferences of children with narcolepsy type 1 between Extended-release sodium oxybate and Non-extended-release oxybates (Sodium oxybate or a medication with the combination of Calcium, magnesium, potassium, and sodium oxybates). The study will also assess the safety, convenience, and tolerability of Extended-release sodium oxybate. Additionally, the researchers aim to assess how well Extended-release sodium oxybate works in treating narcolepsy type 1.
started
Oct 27, 2025
primary completion
Jun 1, 2027
completion
Jul 1, 2027
last updated
Nov 6, 2025
official title
Safety, Convenience, and Tolerability of a Nightly Single Oral Dose of Extended-release Sodium Oxybate in Children
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol